Patients with COVID-19 often also face cardiovascular challenges and associated comorbidities. Understanding how repositioned drugs to treat COVID-19 may impact the cardiovascular health of patients is important.
Live Graph Detail: Targets of the drugs are included (e.g. RNA dependent RNA polymerase, target of remdesivir, IL-7, target of IL-6 inhibitors).
Tags: ANAEMIA, ATRIAL FIBRILLATION, CARDIOPULMONARY FAILURE, CHLOROQUINE, HEPARIN-INDUCED THROMBOCYTOPENIA, IL-6, LEUKAEMIA, LEUKOPENIA, NEUTROPENIA, PURPURA, RNA DEPENDENT RNA POLYMERASE, THROMBOCYTOPENIA, THROMBOSIS